11961 related articles for article (PubMed ID: 10082402)
1. Inflammatory metastatic melanoma.
Flórez A; Sánchez-Aguilar D; Peteiro C; Peñaranda JM; Toribio J
J Cutan Pathol; 1999 Feb; 26(2):105-8. PubMed ID: 10082402
[TBL] [Abstract][Full Text] [Related]
2. Unusual presentation of metastatic amelanotic melanoma of unknown primary origin as a solitary breast lump.
Roy S; Dhingra K; Mandal S; Khurana N
Melanoma Res; 2008 Dec; 18(6):447-50. PubMed ID: 18971788
[TBL] [Abstract][Full Text] [Related]
3. Pigmented mammary Paget disease mimicking cutaneous melanoma.
Meyer-Gonzalez T; Alcaide-Martin A; Contreras-Steyls M; Mendiola M; Herrera-Acosta E; Herrera E
Int J Dermatol; 2010 Jan; 49(1):59-61. PubMed ID: 20465614
[No Abstract] [Full Text] [Related]
4. Sentinel lymph node biopsy in melanoma: assessment of risk.
Manganoni AM; Farisoglio C; Facchetti F; Simoncini E; Pinton PG
Ann Surg Oncol; 2008 Sep; 15(9):2626; author reply 2627. PubMed ID: 18543038
[No Abstract] [Full Text] [Related]
5. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis.
El Shabrawi-Caelen L; Kerl H; Cerroni L
Am J Dermatopathol; 2004 Oct; 26(5):364-6. PubMed ID: 15365366
[TBL] [Abstract][Full Text] [Related]
6. Expression of complement regulator proteins in primary and metastatic malignant melanoma.
Weichenthal M; Siemann U; Neuber K; Breitbart EW
J Cutan Pathol; 1999 May; 26(5):217-21. PubMed ID: 10408345
[TBL] [Abstract][Full Text] [Related]
7. Expression of gp100, MART-1, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group.
de Vries TJ; Smeets M; de Graaf R; Hou-Jensen K; Bröcker EB; Renard N; Eggermont AM; van Muijen GN; Ruiter DJ
J Pathol; 2001 Jan; 193(1):13-20. PubMed ID: 11169510
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of Sox10 immunohistochemical staining for the detection of metastatic melanoma in sentinel lymph nodes.
Blochin E; Nonaka D
Histopathology; 2009 Nov; 55(5):626-8. PubMed ID: 19912373
[No Abstract] [Full Text] [Related]
9. Pathology of the sentinel lymph node in melanoma.
Starz H
Semin Oncol; 2004 Jun; 31(3):357-62. PubMed ID: 15190493
[TBL] [Abstract][Full Text] [Related]
10. Detection of melanoma micrometastasis in sentinel nodes by reverse transcription-polymerase chain reaction correlates with tumor thickness and is predictive of micrometastatic disease in the lymph node basin.
Blaheta HJ; Schittek B; Breuninger H; Sotlar K; Ellwanger U; Thelen MH; Maczey E; Rassner G; Bueltmann B; Garbe C
Am J Surg Pathol; 1999 Jul; 23(7):822-8. PubMed ID: 10403306
[TBL] [Abstract][Full Text] [Related]
11. Selective lymph node dissection in patients with intermediate thickness melanoma: our experience.
Cafiero F; Peressini A; Percivale PL; Rainero ML; Faggioni M; Gipponi M; Queirolo P; Nicolo G; Bertoglio S
Anticancer Res; 2000; 20(1B):497-500. PubMed ID: 10769712
[TBL] [Abstract][Full Text] [Related]
12. Staining of melanocytic neoplasms by melanoma antigen recognized by T cells.
Mehregan DR; Hamzavi I
Am J Dermatopathol; 2000 Jun; 22(3):247-50. PubMed ID: 10871068
[TBL] [Abstract][Full Text] [Related]
13. Atypical fibroxanthoma-like melanoma with Touton-like giant cells.
Lee JS; Kossard S
Am J Dermatopathol; 2007 Oct; 29(5):480-1. PubMed ID: 17890920
[No Abstract] [Full Text] [Related]
14. A new piece in the melanoma mosaic--carcinosarcoma-like melanoma.
Svec A; Wilkinson L; Bury Y; Martin VG
Histopathology; 2009 Sep; 55(3):366-8. PubMed ID: 19723157
[No Abstract] [Full Text] [Related]
15. Paraganglioma-like dermal melanocytic tumor: a case report with particular features.
Cimpean AM; Ceauşu R; Raica M
Int J Clin Exp Pathol; 2009 Nov; 3(2):222-5. PubMed ID: 20126591
[TBL] [Abstract][Full Text] [Related]
16. Idiosyncrasies of scalp melanoma.
Rigual NR; Cheney RT; Iwenofu OH; Li Q; Loree TR; Popat SR; Merzianu M
Laryngoscope; 2007 Aug; 117(8):1354-8. PubMed ID: 17592396
[TBL] [Abstract][Full Text] [Related]
17. The use of LYVE-1 antibody for detecting lymphatic involvement in patients with malignant melanoma of known sentinel node status.
Sahni D; Robson A; Orchard G; Szydlo R; Evans AV; Russell-Jones R
J Clin Pathol; 2005 Jul; 58(7):715-21. PubMed ID: 15976338
[TBL] [Abstract][Full Text] [Related]
18. Small cell type malignant melanoma which developed in a 16-year-old female with a congenital dermal nevus and metastasized 12 years after excision.
Miura K; Harada H; Tsutsui Y
Pathol Int; 1999 Mar; 49(3):247-52. PubMed ID: 10338082
[TBL] [Abstract][Full Text] [Related]
19. Nodal melanocytic nevi in sentinel lymph nodes. Correlation with melanoma-associated cutaneous nevi.
Holt JB; Sangueza OP; Levine EA; Shen P; Bergman S; Geisinger KR; Creager AJ
Am J Clin Pathol; 2004 Jan; 121(1):58-63. PubMed ID: 14750241
[TBL] [Abstract][Full Text] [Related]
20. Tattoo pigment mimics positive sentinel lymph node in melanoma.
Moehrle M; Blaheta HJ; Ruck P
Dermatology; 2001; 203(4):342-4. PubMed ID: 11752827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
